Research Opportunity Announcement

OTA-21-018 

BioData Catalyst Data Management Core Program

Introduction

NHLBI BioData Catalyst is a cloud-based ecosystem providing tools, applications, and workflows 

in secure workspaces (see Figure in Addendum 1). By increasing access to NHLBI datasets and 

innovative data analysis capabilities, BioData Catalyst accelerates efficient biomedical research 

that drives discovery and scientific advancement, leading to novel diagnostic tools, 

therapeutics, and prevention strategies for heart, lung, blood, and sleep disorders. BioData 

Catalyst supports the overall Strategic Vision of NHLBI and, in particular, Objective 7. 

Though the primary goal of the BioData Catalyst program is to build a data science ecosystem, 

at its core, this is a people-centric endeavor. BioData Catalyst is also building a community of 

practice working collaboratively to solve technical and scientific challenges. The community 

includes developers, computer scientists and bioinformaticians who are building and operating 

the cloud-based platform; the data generators who collect and generate the data from NHLBIfunded studies; and platform users who access and compute on the data within the platform. 

To make the BioData Catalyst endeavor successful, data must become a first-class research 

object. Investing time and resources into making research data FAIR - findable, accessible, 

interoperable, and reusable - is critical for ensuring maximum return of the Institute’s 

investment in generating the data. NHLBI wants its research community to be able to easily find 

and use its data assets. NHLBI also wants to ensure that its data can be integrated and 

aggregated and optimally reused by its investigators. 

The Institute faces several challenges in making data a first-class research object. These 

include: 

• Prioritizing and sequencing NHLBI datasets for ingest into BioData Catalyst

• Standardizing (meta)data

o Retrofitting existing datasets by working with data generators

o Promulgating standards for prospective/future data collection

o Using technology to facilitate standardization

• Understanding governance of datasets and translating for BioData Catalyst developers

The Institute has several immediate data management needs. These include ingesting multiple 

data sets of varied data types (electronic health record, research clinic surveys and 

assessments, genotypes, molecular and laboratory, imaging) into BioData Catalyst and the 

number of data sets has increased as a result of the COVID-19 pandemic. To efficiently ingest 

these data sets, a shared understanding between the data generators and the BioData Catalyst 
Research Opportunity Announcement

NHLBI BioData Catalyst Data Management Core Program

Page 2 of 14

developers is required of data formats, structure, standards, and governance. Minimal 

(meta)data standards are required across the BioData Catalyst ecosystem and these standards 

need to be communicated to data generators and NHLBI staff. Standard operating procedures 

for getting data ready for ingest into BioData Catalyst need to be developed.

This solicitation invites applicants with appropriate expertise and capacity to submit a proposal 

to serve as the BioData Catalyst Data Management Core, outlining the functions, roles, and 

responsibilities of such a Core in ensuring the efficient and effective management of data 

before and during ingest into BioData Catalyst. 

 

Authority

This Research Opportunity Announcement (ROA) is issued with the goal of establishing an 

“Other Transactions” (OT) agreement pursuant to 42 U.S.C. § 285b-3. 

Objectives

The NHLBI seeks to establish a Data Management Core (DMC) to support the overall research 

mission of the NHLBI. The overall goals of the DMC will be to:

• Identify and prioritize, in collaboration with NHLBI, data for onboarding into BioData 

Catalyst

• Standardize data and streamline the data onboarding process 

• Maximize value of data through harmonization prior to onboarding

• Identify and develop, as needed, technology to innovate and create efficiencies in the 

above areas

The DMC will interact closely with stakeholders across the NHLBI research enterprise. The DMC 

will work with domain experts relevant to the NHLBI research community (genomics, imaging, 

phenotypes of interest to NHLBI (e.g., heart failure, asthma, sickle cell disease, etc.)) to 

understand what data standards exist and are applicable to the research of the NHLBI 

community. The DMC will educate data generators about data standards and will subcontract 

to particular data generators and consortia to configure their data for ingest into BioData 

Catalyst. The DMC will work with data generators and consortia to facilitate standardization 

and harmonization of their data including harmonization of data with existing NHLBI datasets. 

This will be achieved through proactive promulgation of Common Data Elements (CDEs) and 

common measurement methods. Where necessary, the DMC will also support the data 

generator in retrospectively harmonizing phenotypes to enable integration and aggregation of 

data with existing NHLBI datasets such as NHLBI’s cohort studies. It is anticipated that the DMC 

will develop and/or collate a suite of tools to facilitate phenotype harmonization ranging from 

clearly documented methods to software tools and Jupyter notebooks to artificial intelligence 

and machine learning methods. The DMC will catalog similar tools and guidance for 

standardization of molecular data, for example alignment and variant calling pipelines for 

genomics. 
Research Opportunity Announcement

NHLBI BioData Catalyst Data Management Core Program

Page 3 of 14

The DMC will work with BioData Catalyst developers to understand BioData Catalyst 

architecture, ingest process, and requirements for ingest. The DMC will also work with BioData 

Catalyst developers to develop cloud-based work spaces for data preparation. The DMC will 

also work collaboratively with NHLBI staff on understanding data governance at NHLBI, 

developing data standards, identifying content experts, and recommending guidance to the 

research community. 

It is expected the DMC will take an agile and strategic approach to accomplishing its objectives. 

Nimble subcontracting will be required to bring in subject matter experts as needed and to 

support data generators as they prepare their data. It is expected that the DMC will not have 

all required subject matter experts on their team at project initiation. 

Statement of Objectives and Milestones (SOM)

The activities of the Data Management Core may be grouped into 4 categories: operations, data 

management, data standards, and data technology and these activities are reflected across the 

objectives below.

1.0 Operations

1.1 Plan and implement an NHLBI-inclusive Data Management Core that works 

collaboratively with the NHLBI BioData Catalyst program team, NHLBI leadership, 

data generators, data stewards, coordinating centers, the NHLBI Data Access 

Committee, and the BioData Catalyst Consortium.

Under the guidance of the NHLBI BioData Catalyst (BDC) team, the Awardee will: 

Provide basic administrative support for coordinating and planning meetings, 

drafting agendas, taking notes, providing meeting minutes, and recording / 

monitoring / follow up action items, relevant to DMC activities. This includes 

administrative meeting support for the NHLBI, the Core and its subcontractors, 

and working groups. Meetings may take the form of teleconferences, webinars 

and up to 4 in-person meetings per year. 

1.2 Establish and enable well defined and documented data management practices 

that adhere to FAIR principles (Findable, Accessible, Interoperable, 

Reusable/Reproducible) within NHLBI and its broad research community. Where 

possible, the DMC should leverage existing practices and standards. 

1.3 Implement a comprehensive program and project management practice with the 

expertise and experience to coordinate, monitor, and implement a diverse and 

complex array of activities across multiple research programs. The program must 

incorporate the development of methods for prioritization of curation and ingest 

of data sets into BioData Catalyst that is cognizant of NHLBI leadership priorities 

and the needs of the research community and other relevant stakeholders and is 

consistent with informed consent. The DMC should work with NHLBI staff to 
Research Opportunity Announcement

NHLBI BioData Catalyst Data Management Core Program

Page 4 of 14

establish pathways and processes for seeking NHLBI leadership approval where 

needed. 

Under the guidance of the NHLBI BDC team, the Awardee will: 

Provide day to day project management services, including project plan tracking 

and schedule management through the use of appropriate project management 

software and other electronic tools in order to coordinate and integrate the 

milestone-driven activities, as well as budget monitoring, and risk identification 

and mitigation for all consortium-based projects. 

Implement project modifications as necessary, after consultation with NHLBI. 

Serve as the key point of contact with parties at NHLBI and the BioData Catalyst 

consortium awardees to help coordinate efforts in close collaboration with all 

technical staff. Prepare and distribute detailed project plan status reports and 

other project plan related documentation to the NHLBI and the consortium. 

Oversee the various components of the Core activities with appropriate 

milestones and metrics.

1.3.1 Monitor and report program activity status, risk, cost and schedule 

against approved plans. Reporting should be progress relative to metrics 

which the Core to identifies and develops, in consultation with NHLBI 

leadership, the BioData Catalyst consortium, and other stakeholders.

1.4 The Awardee must embrace the speed and flexibilities of the Other Transaction 

mechanism by taking a more active and direct role than may be usual in helping 

the government foster the success of the initiative. As such, the Awardee cannot 

passively monitor progress but must be responsible for ensuring strategic 

alignment, programmatic oversight and ensuring the government’s interests are 

met. The awardee should quickly identify issues and making recommendations 

to address them. Given changing priorities and/or inadequate progress, the 

DMC must be able to stop a project and pivot efforts and resources toward more 

compelling scientific challenges/needs. 

1.5 Coordinate with and provide financial support to research institutions in order to 

bring in needed outside expertise and to support data generators/data stewards 

in their work to prepare data for ingest. Awardee must have efficient and 

flexible subcontracting processes in place. 

1.6 Regularly communicate and report on activities to stakeholders including NHLBI 

staff and leadership, the NHLBI BioData Catalyst consortium, the BioData 

Catalyst External Expert Panel (EEP), research programs etc. to ensure they have 

an accurate and up to date picture of the core’s activities and plans, and for the 

NHLBI, financial status. Communicate plans and priorities for data curation and 

ingest with time horizons. 
Research Opportunity Announcement

NHLBI BioData Catalyst Data Management Core Program

Page 5 of 14

2.0 Data management

2.1 Publish and maintain a compendium of high value NHLBI data sets to enable the 

research community to understand the available data and assess the utility of 

the data to their research goals including a program to evaluate and maintain an 

assessment of the FAIRness of the data sets consistent with other NIH data 

management and sharing efforts to assess and promote FAIRness.

2.2 Develop a prioritization scheme of how to order data sets for ingest by soliciting 

external experts, EEP and NHLBI leadership input that may also include input 

from the research community. 

2.2.1 Develop a multi-year road map which includes the timelines and 

estimated scope, level of effort, and cost needed to on-board the data 

sets.

2.2.2 Provide regular updates to enable NHLBI, the BioData Catalyst 

Consortium and the research community to understand plans and 

progress on data ingestion including dashboards relating to program 

activities and status. 

2.3 Support data generators/stewards in preparing data for ingest into BioData 

Catalyst, in a consultant type role. This will involve ingestion of varied data types, 

including, but not necessarily limited to, data from electronic health records, 

research clinic surveys and assessments, genotypes, molecular and laboratory 

assays, and imaging procedures. This will involve some combination of 

deidentification, digitization, alignment to data standards, QA/QC checks, 

governance translation, etc. This might involve subcontracting with data 

generators/stewards to accomplish this work. This may involve use to 

tools/workflows developed by BioData Catalyst and/or the DMC. This may 

involve supporting/educating data generators/stewards in working in cloudbased workspaces to accomplish this work.

2.3.1 The DMC should demonstrate expertise in the data types highly relevant 

to the NHLBI research community, including genomics, cardiac and lung 

imaging, and relevant phenotypes, such as heart failure, sickle cell 

anemia, and chronic obstructive pulmonary disease. It is not expected 

that all experts will be at a single institution nor is it expected that all 

expertise will be present in the initial application. The DMC must be able 

to identify the appropriate expertise and be facile at bringing that 

expertise into the DMC. 

2.3.2 The DMC should develop policies and procedures for interacting with 

data generators and their respective coordinating centers (if relevant). 

An example is the Administrative Coordinating Center for the TOPMed 

program. These should include methods for communication and should 
Research Opportunity Announcement

NHLBI BioData Catalyst Data Management Core Program

Page 6 of 14

describe how the DMC will work with data generators to register studies 

in dbGaP, support data harmonization, and support data ingestion into 

BDC. 

2.3.3 The DMC should develop policies and procedures for interacting with the 

BioData Catalyst consortium. These should include methods of 

communication, representation on relevant BDC committees (such as the 

Data Release and Management Working Group (DRMWG)), and how the 

hand-off of data to relevant BDC components will occur. 

3.0 Data standards

3.1 Solicit external/internal expert advice, via working groups or requests for 

information (RFIs), to define enterprise-wide approaches to data standardization 

and publish appropriate guidance to the research community.

3.2 Develop and maintain guidance on data formatting, meta-data model, common 

data elements, ontologies, mappings, etc. This guidance may be data type 

and/or disease specific. The DMC should not develop de novo standards where 

well-accepted, reasonable standards exist. The guidance should be developed in 

consultation with external experts, NHLBI, NLM and other NIH staff and the 

research community. These standards shall be published for wide access by the 

NHLBI research community.

3.3 Ensure that appropriate processes and procedures exist for quality assurance 

and quality control for data being ingested to BioData Catalyst by working with 

BioData Catalyst developers, data generators/stewards, and external/internal 

experts. Provide regular assessments and reporting on quality factors to the 

NHLBI. 

3.4 Publish and maintain data governance procedures/policies for BioData Catalyst. 

Work with BioData Catalyst developers and data generators to implement 

alternative approaches as needed.

4.0 Data technology

4.1 Collate a suite of tools that enable and facilitate ingest of data into BioData 

Catalyst including tools for assessing data readiness, standardizing and 

harmonizing data and preparing data for ingest and validating data including 

compliance with relevant policies and consistency with study participant 

consents following ingest. This objective may require ongoing research into data 

preparation methods using a variety of techniques including artificial intelligence 

and machine learning methods.

5.0 Reporting
Research Opportunity Announcement

NHLBI BioData Catalyst Data Management Core Program

Page 7 of 14

The Awardee will engage with the NHLBI to assess progress and will be required to 

provide reporting updates on a regular schedule. 

5.1 Monitor, assess, and provide reports on the overall status of Core activities 

Under the guidance of the NHLBI PMO, the Awardee will track and monitor 

progress under a unified milestone-based project management framework to 

keep the NHLBI informed of consortium-based projects and overall strategic 

progress. The awardee includes metrics identification, collection and analyses to 

determine if the projects and program are meeting intended goals. Awardee will 

monitor and report on cost, schedule, and performance relative to projections 

and address anomalies and actions which are being taken to address.

5.1.1 Monthly reports

On a monthly basis, the Awardee Business Official (ABO) will submit a 

single report to the Agreements Officer (AO) Scientific Program Director 

(SPD), and the PMO assigned Program Manager consisting of financial 

and technical information, that provides the government with sufficient 

detail to monitor schedule, risk, budget, and overall progress of each 

milestone appearing in this SOM. The NHLBI/NIH will provide a suggested 

template to the Awardee for reporting purposes. Monthly reports are 

due to the NHLBI OT Mail Box (NHLBI_OTA@mail.nih.gov) and to the 

NHLBI/NIH Points of Contact 15 calendar days following the end of each 

calendar month. 

5.3 Monthly meetings

On at least a monthly basis, the Awardee will make the Principal Investigator and 

key personnel available and hold a telephone, WebEx/zoom, and/or in-person 

meeting with the NHLBI/NIH. In addition, the Awardee’s ABO and PI may need to 

be available for direct discussions with the NHLBI SPD, PM and AO as needed.

5.4 Semi-annual reports

Provide semi-annual evaluation reports to NHLBI with respect to metrics for the 

overall program and individual projects. Reports may be used for the BioData 

Catalyst external advisory panel.

6.0 Phasing and potential milestones

6.1 It is expected that the activities to achieve the above Objectives of the DMC will 

be conducted in phases: Initiation, Operationalization, and Maintenance. 

Initiation phase will involve start-up activities, landscape analyses, and 

preliminary work. Operationalization phase will involve establishment of 

standard operating procedures (SOP), policies, and procedures. Maintenance 

phase will involve implementation of plans, ongoing work, and continuous 

monitoring and improvement of processes. Overlap of some activities across 

phases is expected. 
Research Opportunity Announcement

NHLBI BioData Catalyst Data Management Core Program

Page 8 of 14

6.2 A list of potential deliverables by phase are provided below. These are just 

examples and the lists are not exhaustive.

Initiation phase:

• Landscape analysis of work to date and proposed strategy to leverage 

existing work

• Evaluation of high value NHLBI data sets (see list of released and 

backlogged data sets in Addendum 2) 

• Prioritization schema for ordering data sets for ingestion (approved by 

DSLT) and implication to NHLBI data sets

• SOPs for ingesting data into BDC

• Solution for providing stakeholders data ingest status and beta 

implementation 

• Recommendations for enterprise-wide approach for data standardization

• Compendium of existing data standards used by NHLBI studies

• Landscape analysis of available tools

• Review and evaluation of data standardization/harmonization work to 

date 

• OT management plan that outlines how the DMC will manage within the 

Biodata Catalyze eco systems and the various stakeholders.

• Subcontracts for needed expertise or support transitional datasets

Operationalization phase:

• SOP for continuous landscape analysis of datasets

• SOP for periodic data prioritization 

• Subcontracts to data generators, as needed, for pre-ingest data 

standardization

• SOP for maintaining and updating data standards guidance

• Test tools to support data standardization

Maintenance phase:

• Continuous landscape analysis

• Periodic data prioritization

• Develop durable materials (e.g., guidance documents, checklists, etc.) to 

support data generators

• Maintenance and updating of data standards guidance

• Supports users working with data standardization/readiness tools

Eligibility

Organizations

The following entities are eligible to apply under this ROA:

• Higher Education Institutions
Research Opportunity Announcement

NHLBI BioData Catalyst Data Management Core Program

Page 9 of 14

• Public/State Controlled Institutions of Higher Education

• Private Institutions of Higher Education

Nonprofits Other Than Institutions of Higher Education

• Nonprofits with 501(c)(3) IRS Status (Other than Institutions of Higher Education)

• Nonprofits without 501(c)(3) IRS Status (Other than Institutions of Higher Education)

• For-Profit Organizations

• Small Businesses

• For-Profit Organizations (Other than Small Businesses)

Special Award Terms

The complete terms and conditions of each Other Transaction award issued under this ROA are 

subject to negotiation and will be contained in the OT Agreement entered between the NHLBI 

and the Awardee. This Special Award Terms section is provided for informational purposes only 

in order to provide prospective applicants with an understanding of key expectations and terms 

that may differ from traditional NIH award mechanisms. 

Award Criteria and Selection Information

The awardee will be selected through an objective review process. The level of funding for the 

award made under this ROA has not been predetermined but will depend on (1) the objectives 

proposed by the applicant and how well they fit with the goals of the host targeting therapies 

initiative, (2) quality of the proposals received, and (3) budget evaluation of value for dollar. 

The agreement for the award will be negotiated with the eligible entity whose proposals is 

determined to be the most meritorious and provide the best value to the NHLBI toward 

achieving the goals of the DMC and in accordance with the NHLBI priorities.

The NHLBI reserves the right to:

• Select for negotiation all, some, one, or none of the proposals received in response to 

this ROA;

• Segregate portions of resulting awards into components and their associated budget 

and/or milestones that differ from those that have been proposed;

• Accept proposals in their entirety or to select only portions of proposals for award;

• Fund proposals in increments and/or with options for continued work at the end of one 

or more phases, which can consist of more than one milestone;

• Fund proposals of two or more applicant entities as part of a reorganized, consolidated 

consortium operating under an article of collaboration, teaming arrangement, or other 

means acceptable to the NHLBI;

• Fund proposers as sub-awardees of a separate Coordinating Center entity to be 

established by the NHLBI;

• Request additional documentation (certifications, etc.); and
Research Opportunity Announcement

NHLBI BioData Catalyst Data Management Core Program

Page 10 of 14

• Remove proposers from award consideration should the parties fail to reach a finalized, 

fully executed agreement, or the proposer fails to provide requested additional 

information in a timely manner.

Proposal Process

Submission in response to this ROA occurs in two stages. Stage 1 requires submitting a Letter of 

Request (see >$500k process on NHLBI web site). If invited by NHLBI, the applicant shall 

proceed to Stage 2, which requires submitting a full proposal using eRA ASSIST.

STAGE 1 - NHLBI Biodata Catalyst Data Management Core Program Initial Eligibility and 

Preliminary Review 

NHLBI will review and determine whether the applicant should proceed with completing the full 

proposal submission. The NHLBI may request additional information be provided by the 

applicant to complete their initial eligibility and preliminary review. These requests will be sent 

to the applicant via email. Applicants are strongly encouraged to provide the requested 

information in a timely manner to prevent any potential delays in the review process. Proposals 

that do not meet the initial Biodata Catalyst Data Management Core Program ROA program and 

eligibility criteria will be rejected.

Stage 1 will be patterned after the NHLBI >$500K process (https://www.nhlbi.nih.gov/grantsand-training/policies-and-guidelines/applications-with-direct-costs-of-500000-or-more-in-anyone-year) that includes a Letter of Request addressed to Dr. David Goff, DCVS Director, Chair of 

the Data Science Leadership Team, outlining major elements of the proposed core, personnel, 

budget, and feasibility. 

In order for the NHLBI to make an informed decision about whether to accept a proposed 

application for review, the Letter of Request (see link) should not exceed five (5) pages and 

should include:

• The proposed project title

• The anticipated solicitation (Funding Opportunity Announcement/Research Opportunity 

Announcement 

• The anticipated application receipt date

• The expected start date to launch the DMC

• The key personnel (the eRA Commons user id must be included for the PI or contact PI)

• The submitting organization or institution

• Brief description of the overall goals of the DMC, their rationale, and how they will 

support the overall NHLBI research mission 

• Brief description of the main DMC activities and how they will be accomplished

• Brief description of any prior work or preliminary work in this area including data 

management across the varied data types described above
Research Opportunity Announcement

NHLBI BioData Catalyst Data Management Core Program

Page 11 of 14

• Brief description of program and project management approach and plan, with 

particular attention to how milestones will be planned, monitored, reported, and, when 

appropriate, shared with stakeholders

• Brief description of DMC personnel including their relevant expertise and history in 

conducting the type of activities necessary for establishment and implementation of the 

DMC including data management, data harmonization, across the varied data types 

described above

• Demonstrated ability to efficiently issue subcontracts

• Demonstrated ability to operate in a highly collaborative and flexible manner in a 

complex program as required by the Other Transaction mechanism

• Direct and total costs by phase of the project – generally a one-paragraph description of 

major sources of costs in the study using one of the two tables provided via the 

following link: https://www.nhlbi.nih.gov/files/docs/500K%20Budget%20Tables_2018-

09-17.xlsx 

• Specify (1) any funding provided by other entities (federal agencies, 

foundations, companies), and (2) any goods or services (and their value) 

provided by any of these parties. 

• A description of any anticipated agreements with third-parties relevant to the proposed 

project, including details about any provisions or restrictions related to intellectual 

property, publication, and data sharing

STAGE 2 - Full Proposal 

If upon review of the Letter of Request the NHLBI determines the proposed research to be in 

scope and hold significant promise for achieving the objectives of this ROA, the applicant will be 

invited to submit a full proposal. The full proposal will be submitted via eRA ASSIST following 

instructions that will be provided to the applicant. 

The full proposal should include information in the following areas:

• Additional administrative information about the applicant and institution or organization 

(name, address, entity and Principal Investigator NIH Commons Registration information), 

including SAM information and DUN and Bradstreet number, human and animal assurance 

approvals as appropriate.

• Project Plan uploaded as searchable PDF format in a font size of 11 or 12 point and font type 

of Arial or Times New Romans. Margins must be 1-inch wide (top, bottom, left, and right). The 

project plan must not exceed 30 pages in length. Biosketches must not exceed 4 pages in length 

and are not counted in the page limit. Also excluded from the page limitation are cover sheets, 

letters from collaborators and consultants, and representation and certification documents.

• Budget reflecting the total cost proposed, accounting for cost share amounts offered by the 

applicant. (If proposing F&A include a negotiated federal rate approval.)

Project Plan
Research Opportunity Announcement

NHLBI BioData Catalyst Data Management Core Program

Page 12 of 14

The Project Plan should generally include the following elements:

• Project Summary: Description of the overall goals of the DMC and the activities that will 

support its implementation.

• Detailed description of how each Objective will be met and how progress will be 

monitored. Applicant should describe how innovative practices and approaches will be 

used to accomplish the Objectives. 

• Operational Milestone Based Plan: The plan should describe all proposed Operational 

Milestones by Objective and by each Phase. Each Operational Milestone should include 

objective completion criteria and an anticipated completion date, as well as a 9-12 

month timeline showing each milestone in a Gantt chart like format. 

• Financial Contingency Plan: Potential risks, mitigation strategies, and associated costs, 

including a description of a viable source to cover these costs (other than NHLBI and not 

including co-funding). 

• Team Organization: Team structure, leadership and communications plan, including 

biosketches of individuals identified as the principal investigator and all key personnel.

• Resources and Environment: Resources available to the project and environment in 

which the activities will be performed.

• References

Budget 

The Budget section of the application must provide a realistic, fully justified budget and cost 

proposal for performing the work over a specified period of performance needed to accomplish 

project objectives.

Funding will be obligated annually, with bi-annual restrictions in place. An initial amount of 

funding, covering the execution of the first half of the activity period, will be made available 

(unrestricted) upon award. Subject to NHLBI program staff review and approval, additional biannual funding will be unrestricted based on achievement of planned project schedule 

objectives. 

Provide the overall expected cost for each of the following categories:

• Personnel 

• Equipment 

• Travel

• Subawards/subcontracts/consultants 

• Other direct costs

• Total cost (with indirect costs included)

• Proposed Cost Share contribution
Research Opportunity Announcement

NHLBI BioData Catalyst Data Management Core Program

Page 13 of 14

Submission and Contact Information

For best consideration, initial Stage 1 Letters of Request should be submitted via email by 

Tuesday, February 22, 2022, by 5 PM EDT to NHLBI_OTA@mail.nih.gov. This mailbox will also 

be used to answer questions. If invited to submit a Stage 2 full proposal, the applicant will be 

provided specific instructions for how to submit via eRA ASSIST. 

Financial and administrative questions should be addressed to Benjamin Sakovich, NHLBI 

Agreements Officer, Benjamin.Sakovich@nih.gov. 

Technical questions should be addressed to the NHLBI Division that best aligns with the study: 

Christopher Miller at christopher.miller4@nih.gov 

A note about eRA Registration 

NHLBI uses the eRA Commons system to administer OT awards. If you are invited to submit a 

full proposal in eRA ASSIST, you will need to be registered in eRA Commons, which can take 

some time to complete – as many as several weeks in some cases. Therefore, if you are 

considering submitting a proposal and are not yet registered in eRA, it is highly recommended 

that you begin the process of registering your organization, Program Director/Principal 

Investigator (PD/PI) and Signing Official (SO) in eRA Commons as soon as possible to avoid 

possible award processing delays. To register, please follow the instructions via this website: 

https://public.era.nih.gov/commons/public/registration/registrationInstructions.jsp. 

1. Complete the online Institution Registration Form and click Submit. 

2. The NIH database will send you an email with the link to confirm your email address. 

3. Once your email address is verified, the NIH will review your request and let you 

know of the result via email. 

4. If your request is denied, you will get an email notifying you of the reason. 

5. If your request is approved, you will get an email with your Commons User ID and 

temporary password. 

6. Log into Commons with the temporary password and the system will prompt you to 

change temporary password to a permanent one. Your SO will be prompted to 

electronically sign your registration request. (Please review your registration 

information carefully.) 

7. Once your SO has electronically signed the request, your organization will be active in 

Commons and you may create and maintain additional accounts for your institution 

staff. 
Research Opportunity Announcement

NHLBI BioData Catalyst Data Management Core Program

Page 14 of 14

To complete the registration above, you may need to register for the following if you haven’t 

done so already: 

Dun & Bradstreet Number (DUNS) - https://fedgov.dnb.com/webform/ 

Employer Identification Number (EIN)- https://www.irs.gov/businesses/smallbusinesses-self-employed/apply-for-an-employer-identification-number-ein-online 

Small Business Administration (SBA) - https://www.sbir.gov/registration 

System for Award Management (SAM) - https://www.sam.gov/SAM/ 
HLBS Scientific Community Served by Enterprise
Jira Ticket Number Study/Data Name Status Comments COVID-19 Sickle Cell Genomic

Phenotypic/

Clinical Imaging EHR

MONITOR-715 1000 Genomes BDCatalyst Released "BDCatalyst Released" Indicates availability 

across the entire ecosystem - - X X - -

MONITOR-716 TOPMed Freeze 8 -- Batch 3 BDCatalyst Released "BDCatalyst Released" Indicates availability 

across the entire ecosystem - - X X - -

MONITOR-712 TOPMed Freeze 8 -- Batch 2 BDCatalyst Released "BDCatalyst Released" Indicates availability 

across the entire ecosystem - - X X - -

MONITOR-710 Freeze 8 Combined Exchange Area BDCatalyst Released "BDCatalyst Released" Indicates availability 

across the entire ecosystem - - X X - -

MONITOR-723 TOPMed Freeze 8 -- Batch 1 BDCatalyst Released "BDCatalyst Released" Indicates availability 

across the entire ecosystem - - X X - -

MONITOR-722 TOPMed Freeze 5b BDCatalyst Released "BDCatalyst Released" Indicates availability 

across the entire ecosystem - - X X - -

MONITOR-708 Modification of Metadata Fields BDCatalyst Released "BDCatalyst Released" Indicates availability 

across the entire ecosystem - - - - - -

MONITOR-818 Additional TOPMed Studies BDCatalyst Released "BDCatalyst Released" Indicates availability 

across the entire ecosystem - - X X - -

MONITOR-755 CureSCi - MSH (via BioLINCC) BDCatalyst Released "BDCatalyst Released" Indicates availability 

across the entire ecosystem - X - X - -

MONITOR-756 CureSCi - CSSCD (via BioLINCC) BDCatalyst Released "BDCatalyst Released" Indicates availability 

across the entire ecosystem - X - X - -

MONITOR-742 PCGC (CMG/Wagner) BDCatalyst Released "BDCatalyst Released" Indicates availability 

across the entire ecosystem - - X - -

MONITOR-849 New data from TOPMed combined EA BDCatalyst Released "BDCatalyst Released" Indicates availability 

across the entire ecosystem - - X X - -

MONITOR-810 TOPMed Freeze 8 Corrected Zip Files BDCatalyst Released "BDCatalyst Released" Indicates availability 

across the entire ecosystem - - X X - -

MONITOR-753 CureSCi - CIBMTR (via BioLINCC) - aka HCT for SCD BDCatalyst Released "BDCatalyst Released" Indicates availability 

across the entire ecosystem - X - X - -

MONITOR-764 TOPMed Parent Study Updates BDCatalyst Released "BDCatalyst Released" Indicates availability 

across the entire ecosystem - - - X - -

MONITOR-759 PETAL - ORCHID BDCatalyst Released "BDCatalyst Released" Indicates availability 

across the entire ecosystem

X - - - - -

MONITOR-906 Additional Parent Freeze8 Study (CARDIA) BDCatalyst Released "BDCatalyst Released" Indicates availability 

across the entire ecosystem - - X X - -

MONITOR-920 PETAL - ORCHID (re-ingestion) BDCatalyst Released "BDCatalyst Released" Indicates availability 

across the entire ecosystem

X - - - - -

MONITOR-760 PETAL - RED CORAL (COVID-19) BDCatalyst Released "BDCatalyst Released" Indicates availability 

across the entire ecosystem

X - - - X -

MONITOR-935 PCGC SRA Data Pre-Ingestion

"Pre-Ingestion" - Data is available and 

undergoing QA/QC in NHLBI buckets

before ingestion.

- -

X

- - -

MONITOR-1051

Immune response to Life-Threatening Respiratory Infections in 

Children and Young Adults (COVID-19) Prioritized

"Prioritized" - Data is prioritized by the BDC CCB 

for ingestion and is in the process of being 

uploaded to NHLBI buckets. X

- -

X

- -

MONITOR-971 TOPMed Freeze 9 - Batch 3 Prioritized "Prioritized" - Data is prioritized by the BDC CCB 

for ingestion and is in the process of being 

uploaded to NHLBI buckets.

- -

X X

- -

MONITOR-852 BioLINCC Phase 2 (16 TOPMed Studies) Prioritized "Prioritized" - Data is prioritized by the BDC CCB 

for ingestion and is in the process of being 

uploaded to NHLBI buckets.

- -

X

- -

MONITOR-831 C3PO (COVID-19) Prioritized "Prioritized" - Data is prioritized by the BDC CCB 

for ingestion and is in the process of being 

uploaded to NHLBI buckets.

X

-

X

- -

MONITOR-851 NuMoM2b Heart Health Study Prioritized "Prioritized" - Data is prioritized by the BDC CCB 

for ingestion and is in the process of being 

uploaded to NHLBI buckets.

- -

X X

- -

MONITOR-832 ACTIV4a (COVID-19) Prioritized "Prioritized" - Data is prioritized by the BDC CCB 

for ingestion and is in the process of being 

uploaded to NHLBI buckets.

X

- - - - -

MONITOR-1054 ACTIV4b (COVID-19) Prioritized "Prioritized" - Data is prioritized by the BDC CCB 

for ingestion and is in the process of being 

uploaded to NHLBI buckets.

X

- - - - -

MONITOR-758 CureSCi - BabyHug (via BioLINCC) Released by Gen3

"Released by Gen3" - Data is indexed by Gen3 

and available for downstream processing by the 

remaining BDC platform teams prior to BDCwide release

-

X

-

X

- -

MONITOR-919 Additional TOPMed Freeze 8 Studies (CATHGen) Released by Gen3 "Released by Gen3" - Data is indexed by Gen3 

and available for downstream processing by the 

remaining BDC platform teams prior to BDCwide release

-

X X

- -

MONITOR-887 Additional TOPMed Freeze 8 Studies (PMBB) Released by Gen3 "Released by Gen3" - Data is indexed by Gen3 

and available for downstream processing by the 

remaining BDC platform teams prior to BDCwide release

-

X X

- -

MONITOR-1014 TOPMed Freeze 9 - Batch 2 Released by Gen3 "Released by Gen3" - Data is indexed by Gen3 

and available for downstream processing by the 

remaining BDC platform teams prior to BDCwide release

-

X X

- -

MONITOR-757 CureSCi - STOP-II (via BioLINCC) Released by Gen3 "Released by Gen3" - Data is indexed by Gen3 

and available for downstream processing by the 

remaining BDC platform teams prior to BDCwide release

-

X X

- -

MONITOR-754 CureSCi - Walk-PhaSST (via BioLINCC) Released by Gen3 "Released by Gen3" - Data is indexed by Gen3 

and available for downstream processing by the 

remaining BDC platform teams prior to BDCwide release

-

X X

- -

MONITOR-817 TOPMed Freeze 9 - Batch 1 Released by Gen3 "Released by Gen3" - Data is indexed by Gen3 

and available for downstream processing by the 

remaining BDC platform teams prior to BDCwide release

- -

X X

- -

MONITOR-707 BioLINCC (Phase I) - Training Data (CAMP, Framingham) Released by Gen3 "Released by Gen3" - Data is indexed by Gen3 

and available for downstream processing by the 

remaining BDC platform teams prior to BDCwide release

- -

X

- -

MONITOR-888 BioLINCC (Phase 1) - Training Data (Digitalis) Released by Gen3 "Released by Gen3" - Data is indexed by Gen3 

and available for downstream processing by the 

remaining BDC platform teams prior to BDCwide release

- - -

X

- -

MONITOR-709 COPDGene Image Data (Phase I) Backlog

"Backlog" - Data is in our queue but not ready 

for ingestion due to administrative or other 

actions required (e.g. - Institutional Certification, 

dbGaP Registration etc )

- - - -

X

-

MONITOR-713 COPDGene Image Data (Phase II) Backlog "Backlog" - Data is in our queue but not ready 

for ingestion due to administrative or other 

actions required (e.g. - Institutional Certification, 

dbGaP Registration etc )

- - - -

X

-

MONITOR-1029 TOPMed Freeze 9 - CARE_PACT Backlog

This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

- -

X X

- -

MONITOR-1028 TOPMed Freeze 9 - CARE_BADGER Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

- -

X X

- -

MONITOR-1027 TOPMed Freeze 9 - GGAF Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

- -

X X

- -
MONITOR-1026 TOPMed Freeze 9 - LTRC Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XX

--

MONITOR-1025 TOPMed Freeze 9 - BioMe Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XX

--

MONITOR-1024 TOPMed Freeze 9 - OMG_SCD Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XX

--

MONITOR-1023 TOPMed Freeze 9 - EGCUT Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XX

--

MONITOR-1022 TOPMed Freeze 9 - CHIRAH Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

X

X

--

MONITOR-1021 TOPMed Freeze 9 - ChildrensHS_MetaAir Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

X

X

--

MONITOR-1020 TOPMed Freeze 9 - ChildrensHS_IGERA Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XX

--

MONITOR-1019 TOPMed Freeze 9 - ChildrensHS_GAP Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XX

--

MONITOR-1018 TOPMed Freeze 9 - PMBB_AF Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XX

--

MONITOR-1017 TOPMed Freeze 9 - CATHGEN Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

X

X

--

MONITOR-1015 TOPMed Freeze 9 - REDS-III_Brazil Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XX

--

MONITOR-1016 TOPMed Freeze 9 - MLOF Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XX

--

MONITOR-962 TOPMed Freeze 9 - MGH_AF Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XX

--

MONITOR-995 TOPMed Freeze 9 - SAPPHIRE_asthma Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XX

--

MONITOR-969 TOPMed Freeze 9 - GenSalt Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XX

--

MONITOR-959 TOPMed Freeze 9 - Partners Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XX

--

MONITOR-958 TOPMed Freeze 9 - JHS Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XX

--

MONITOR-957 TOPMed Freeze 9 - Amish Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XX

--

MONITOR-956 TOPMed Freeze 9 - CFS Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XX

--

MONITOR-994 TOPMed Freeze 9 - MPP Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XX

--

MONITOR-993 TOPMed Freeze 9 - ECLIPSE Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XX

--

MONITOR-992 TOPMed Freeze 9 - PharmHU Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XX

--

MONITOR-988 TOPMed Freeze 9 - GENAF Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XX

--

MONITOR-987 TOPMed Freeze 9 - DECAF Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XX

--

MONITOR-986 TOPMed Freeze 9 - INSPIRE_AF Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XX

--

MONITOR-985 TOPMed Freeze 9 - AFLMU Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XX

--
MONITOR-984 TOPMed Freeze 9 - Sarcoidosis Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XX

--

MONITOR-983 TOPMed Freeze 9 - miRhythm Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XX

--

MONITOR-981 TOPMed Freeze 9 - DHS Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XX

--

MONITOR-977 TOPMed Freeze 9 - Mayo_VTE Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XX

--

MONITOR-975 TOPMed Freeze 9 - GOLDN Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

X

X

--

MONITOR-973 TOPMed Freeze 9 - HCHS_SOL Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

X

X

--

MONITOR-963 TOPMed Freeze 9 - Samoan Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XX

--

MONITOR-747 National Sleep Research Resource (NSRR) Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XXX

-

MONITOR-846 SHS/C4R (COVID-19) Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

X

--

X

--

MONITOR-845 SPIROMICS/C4R (COVID-19) Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

X

--

X

--

MONITOR-844 SARP/C4R (COVID-19) Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

X

--

X

--

MONITOR-843 REGARDS/C4R (COVID-19) Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

X

--

X

--

MONITOR-842 NOMAS/C4R (COVID-19) Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

X

--

X

--

MONITOR-841 MESA/C4R (COVID-19) Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

X

--

X

--

MONITOR-840 MASALA/C4R (COVID-19) Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

X

--

X

--

MONITOR-839 JHS/C4R (COVID-19) Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

X

--

X

--

MONITOR-838 HCHS/C4R (COVID-19) Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

X

--

X

--

MONITOR-837 FHS/C4R (COVID-19) Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

X

--

X

--

MONITOR-836 FIP/C4R (COVID-19) Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

X

--

X

--

MONITOR-835 COPDGene/C4R (COVID-19) Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

X

--

X

--

MONITOR-834 CARDIA/C4R (COVID-19) Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

X

--

X

--

MONITOR-833 ARIC/C4R (COVID-19) Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

X

--

X

--

MONITOR-830 POPS/CARING (COVID-19) Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

XX

-

XXX

MONITOR-829 PRISM/CARING (COVID-19) Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

X

--

X

--

MONITOR-828 MUSIC/CARING (COVID-19) Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

XX

-

XXX

MONITOR-827 PETALNet - Blue Coral (COVID-19) Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

X

--

XX

-
MONITOR-976 TOPMed Freeze 9 - GENOA Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XX

--

MONITOR-991 TOPMed Freeze 9 - CHS Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XX

--

MONITOR-990 TOPMed Freeze 9 - TOPCHeF Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XX

--

MONITOR-989 TOPMed Freeze 9 - Africa6k Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XX

--

MONITOR-982 TOPMed Freeze 9 - walk_PHaSST Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

X

X

--

MONITOR-980 TOPMed Freeze 9 - SARP Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

X

X

--

MONITOR-979 TOPMed Freeze 9 - THRV Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XX

--

MONITOR-978 TOPMed Freeze 9 - AustralianFamilialAF Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XX

--

MONITOR-974 TOPMed Freeze 9 - HyperGEN Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XX

--

MONITOR-972 TOPMed Freeze 9 - GeneSTAR Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

X

X

--

MONITOR-970 TOPMed Freeze 9 - SAFS Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XX

--

MONITOR-968 TOPMed Freeze 9 - CCAF Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XX

--

MONITOR-967 TOPMed Freeze 9 - BAGS Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XX

--

MONITOR-966 TOPMed Freeze 9 - VU_AF Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XX

--

MONITOR-965 TOPMed Freeze 9 - WGHS Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XX

--

MONITOR-964 TOPMed Freeze 9 - HVH Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XX

--

MONITOR-961 TOPMed Freeze 9 - VAFAR Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XX

--

MONITOR-960 TOPMed Freeze 9 - EOCOPD Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XX

--

MONITOR-717 TOPMed Combined Exchange Area Data Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XX

--

MONITOR-739 Framingham Geocoding Data Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XX

--

MONITOR-749 Lung MAP Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XXX

-

MONITOR-748 Lung Health Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XX

--

MONITOR-746 RURAL Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

---

X

--

MONITOR-745 RefLung Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XX

--

MONITOR-752 BioLINCC Controlled Access Data (Phase 3) Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

---

X

--

MONITOR-799 HyperGEN (Echo) Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

----

X

-
MONITOR-798 CHS (Echo) Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

----

X

-

MONITOR-797 HeartShare (Echo) Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

----

X

-

MONITOR-796 INDIE (Echo) Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

----

X

-

MONITOR-795 NEAT (Echo) Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

----

X

-

MONITOR-794 RELAX (Echo) Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

----

X

-

MONITOR-793 Framingham (Echo) Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

----

X

-

MONITOR-792 CARDIA (Echo) Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

----

X

-

MONITOR-791 SOL (Echo) Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

----

X

-

MONITOR-790 ARIC (Echo) Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

----

X

-

MONITOR-789 MESA (Echo) Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

----

X

-

MONITOR-743 HeartShare Backlog This is not a complete list of TOPMed Freeze 9 

studies, just a list of the studies we were alerted 

were ready for ingestion by the former TOPMed 

DCC. More will be added as they are ready.

--

XXXX